AB

Andreas Bergmann

AA Adrenomed Ag: 2 patents #1 of 1Top 100%
BG B.R.A.H.M.S Gmbh: 2 patents #1 of 5Top 20%
RT Rodin Therapeutics: 1 patents #2 of 6Top 35%
SN Snaptrack: 1 patents #7 of 42Top 20%
SG Sphingotec Gmbh: 1 patents #1 of 2Top 50%
Overall (2019): #19,933 of 560,194Top 4%
7
Patents 2019

Issued Patents 2019

Showing 1–7 of 7 patents

Patent #TitleCo-InventorsDate
10520512 Method for predicting the risk of a subject for contracting diabetes mellitus and/or metabolic syndrome or for diagnosing metabolic syndrome in a subject Olle Melander 2019-12-31
10456364 Use of procalcitonin (PCT) in risk stratification and prognosis of patients with a primary, non-infectious disease Joachim Struck 2019-10-29
10421756 Heterobicyclic N-aminophenyl-amides as inhibitors of histone deacetylase Martin R. Jefson, John A. Lowe, III, Fabian Dey, Andreas Schoop 2019-09-24
10340884 Arrangement comprising a DMS filter and a steep right edge 2019-07-02
10254289 In vitro method for early or differential diagnosis or prognosis of myocardial infarction in a patient Nils Morgenthaler, Jana Papassotiriou, Joachim Struck, Leong Ng 2019-04-09
10227405 Methods of modulating the activity of adrenomedullin in a subject in need of regulation of fluid balance by administering an anti-adrenomedullin (ADM) antibody or an anti-ADM antibody fragment 2019-03-12
10221238 Method of modulating the activity of adrenomedullin in a subject in need of therapeutic intervention for organ dysfunction or organ failure associated with adranomedullin (ADM) activity by administering an anti-adrenomedullin (ADM) antibody or an anti-ADM antibody fragment to the subject 2019-03-05